Oxford Technology Venture Capital Trust Plc
Unaudited Half-Yearly Report
For the period
1 March 2016 to 31 August 2016
Financial Headlines
6 Months Ended
31 August 2016 |
Year Ended
29 February 2016 | |
Net Assets at Period End
| £3.24m | £3.33m |
Net Asset Value per Share
| 59.7p | 61.2p |
Cumulative Dividend per Share
| 54.0p | 52.7p |
Total NAV Return per Share
| 113.7p | 113.9p |
Share Price
| 38.0p | 40.5p |
Earnings per Share | (0.2)p | (3.8)p |
Company Number: 3276063
Registered Address: The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA
Statement on behalf of the Board
I am pleased to present the unaudited results for the six month period ended 31 August 2016.
Results and dividends
The Company's net asset value (NAV) per share has reduced from 61.2p at 29 February 2016 by 1.5p to 59.7p at 31 August 2016. This 1.5p per share movement in NAV is the sum of a reduction in underlying NAV per share of 0.2p and the payment of a 1.3p per share final revenue dividend on 20 July 2016.
Portfolio review
The Directors have reviewed the valuations of each investee company in the unquoted portfolio but have made only minor changes. The largest holding in the portfolio, that of Select Technology, increased modestly due to continued profitable growth. Our very small holding in DHA was exited at around book value for cash.
The Company did not participate in the Scancell placing and open AIM offer due to restrictions imposed by VCT rules. The Scancell share price remained broadly stable through the period and ended the half year period flat at 17.5p per share.
Shareholders should remain aware that the portfolio is very concentrated with just two holdings - Scancell and Select Technology - representing over 85% of NAV. The value of the portfolio is thus very sensitive to changes in valuations of these holdings.
The Directors continue to take an active interest in the investee companies and look forward to continuing to work with OTM to maximise shareholder value and to secure profitable exits from these investee companies at the appropriate time and to enable further dividends to be paid.
Liquidity
At period end we had net current assets of just over £143,000.
VCT qualifying status
The Board has procedures in place to ensure that the Company continues to comply with the conditions laid down by HMRC for maintaining approval as a VCT.
Presentation of half-yearly report
In order to reduce the length of this report, we have omitted details of the Company's objectives and investment strategy, its Advisers and Registrars and how to buy and sell shares in the Company. These details are all included in the Annual Reports, which, together with previous half-yearly reports, are available for viewing on the Oxford Technology website.
Outlook
The last six months has seen a number of changes to qualification conditions for VCTs. However, as we are not looking to invest in new companies we do not believe that these changes will give rise to any issues for our Company. Likewise any uncertainties surrounding the departure from the EU are unlikely to affect us directly. We were pleased to welcome a large number of shareholders to our AGM in July. John Chiplin, the new chairman of one of our investee companies, Scancell, gave a presentation that is available for download from the Oxford Technology website.
The Directors' view remains that the portfolio - though concentrated - is well positioned for growth and continued cash generation. We continue to work to maximise value for shareholders and will, as per our stated strategy, continue to seek to crystallise this value and distribute to shareholders via dividend payments when valuation and liquidity allow.
Finally I would like to take this opportunity to thank shareholders for their continued support.
Alex Starling
Chairman
19 October 2016
Investment Portfolio as at 31 August 2016
Company | Description | Net Cost of investment £'000 |
Carrying value at 31/8/16
£'000 | Change in value for the 6 month period £'000 |
% Equity held
OT1 |
% Equity held
All OT |
%
of fund investment value |
Select Technology
| Photocopier interfaces | 488 | 1,567 | 30 | 30.0 | 58.5 | 50.6 |
Scancell
(bid price 17.5p) | Antibody based cancer therapeutics | 344 | 1,205 | - | 2.6 | 4.4 | 38.8 |
Getmapping
| Aerial photography | 518 | 224 | - | 3.9 | 3.9 | 7.2 |
Biocote | Bactericidal powder coating | 85 | 106 | - | 6.6 | 6.6 | 3.4 |
Total Investments
| 1,435 | 3,102 | 30 | 100% | |||
Other Net Assets |
143 | ||||||
Net Assets |
3,245 |
Responsibility Statement of the Directors in respect of the half-yearly report
We confirm that to the best of our knowledge:
On behalf of the Board:
Alex Starling
Chairman
19 October 2016
Income Statement
Six months to 31 Aug 2016 | Six months to 31 Aug 2015 | Year to 29 February 2016 | |||||||
Revenue | Capital | Total | Revenue | Capital | Total | Revenue | Capital | Total | |
£'000 | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
Gain/(Loss) on disposal of fixed asset investments | - | - | - | - | - | - | - | - | - |
Gain/(Loss) on valuation of fixed asset investments | - | 30 | 30 | - | 193 | 193 | - | (265) | (265) |
Other income | - | - | - | - | - | - | 154 | - | 154 |
Investment management fees | (4) | (13) | (17) | (4) | (13) | (17) | (9) | (26) | (35) |
Other expenses | (24) | - | (24) | (28) | - | (28) | (60) | - | (60) |
Return on ordinary activities before tax | (28) | 17 | (11) | (32) | 180 | 148 | 85 | (291) | (206) |
Taxation on ordinary activities | - | - | - | - | - | - | - | - | - |
Return on ordinary activities after tax | (28) | 17 | (11) | (32) | 180 | 148 | 85 | (291) | (206) |
Earnings per share - basic and diluted | (0.5)p | 0.3p | (0.2p) | (0.6)p | 3.4p | 2.8p | 1.5p | (5.3)p | (3.8p) |
The Company has no recognised gains or losses other than the results for the period as set out above. Accordingly a Statement of Comprehensive Income is not required.
Balance Sheet
As at 31 Aug 2016 | As at 31 Aug 2015 | As at 29 February 2016 | ||||
£'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
Fixed asset investments*
| 3,102 | 3,545 | 3,081 | |||
Current assets: | ||||||
Debtors | 18 | 17 | 2 | |||
Creditors: | ||||||
Amounts falling due within one year | (6) | (4) | (9) | |||
Cash at Bank | 131 | 123 | 253 | |||
Net current assets | 143 | 136 | 246 | |||
Net assets | 3,245 | 3,681 | 3,327 | |||
Called up equity share capital | 543 | 543 | 543 | |||
Share premium | 176 | 176 | 176 | |||
Unrealised capital reserve | 1,666 | 3,297 | 1,346 | |||
Profit and Loss account reserve | 860 | (335) | 1,262 | |||
Total equity shareholders' funds | 3,245 | 3,681 | 3,327 | |||
Net asset value per share | 59.7p | 67.8p | 61.2p |
* At fair value through profit and loss
Statement of Changes in Equity
Share Capital £'000 | Share Premium £'000 |
Unrealised Capital Reserve
£'000 |
Profit & Loss
Reserve £'000 |
Total
£'000 | |
As at 1 March 2015 | 543 | 176 | 3,104 | (290) | 3,533 |
Revenue return on ordinary activities after tax | - | - | - | (32) | (32) |
Expenses charged to capital | - | - | - | (13) | (13) |
Current period gain on fair value of investments | - | - | 193 | - | 193 |
Balance as at 31 August 2015 | 543 | 176 | 3,297 | (335) | 3,681 |
As at 1 March 2015 | 543 | 176 | 3,104 | (290) | 3,533 |
Revenue return on ordinary activities after tax | - | - | - | 85 | 85 |
Expenses charged to capital | - | - | - | (26) | (26) |
Current period losses on fair value of investments | - | - | (265) | - | (265) |
Movement in reserves | - | - | (1,493) | 1,493 | - |
Balance as at 29 February 2016 | 543 | 176 | 1,346 | 1,262 | 3,327 |
As at 1 March 2016 | 543 | 176 | 1,346 | 1,262 | 3,327 |
Revenue return on ordinary activities after tax | - | - | - | (28) | (28) |
Expenses charged to capital | - | - | - | (13) | (13) |
Current period gains on fair value of investments | - | - | 30 | - | 30 |
Prior years' losses now realised | - | - | 290 | (290) | - |
Dividends paid | - | - | - | (71) | (71) |
Balance as at 31 August 2016 | 543 | 176 | 1,666 | 860 | 3,245 |
Statement of Cash Flows
Six months to 31 Aug 2016 | Six months to 31 Aug 2015 | Year to 29 February 2016 | |
£'000 | £'000 | £'000 | |
Cash flows from operating activities | |||
Return on ordinary activities before tax | (11) | 148 | (206) |
Adjustments for: | |||
(Increase)/decrease in debtors | (15) | (14) | - |
Increase/(decrease) in creditors | (4) | (4) | 1 |
Gain on disposal of fixed asset investments | - | - | - |
Loss/(gain) on valuation of fixed asset
investments | (30) | (193) | 265 |
Net cash generated from operating activities | (60) | (63) | 60 |
Cash flows from investing activities | |||
Purchase of fixed asset investments | - | - | - |
Sale of fixed asset investments | 9 | - | 7 |
Total cash flows from investing activities | 9 | - | 7 |
Cash flows from financing activities | |||
Dividends paid | (71) | - | - |
Total cash flows from financing activities | (71) | - | - |
Increase/(decrease) in cash and cash equivalents | (122) | (63) | 67 |
Opening cash and cash equivalents | 253 | 186 | 186 |
Closing cash and cash equivalents | 131 | 123 | 253 |
Notes to the Half-Yearly Report
1. Basis of preparation
The unaudited half-yearly results which cover the six months to 31 August 2016 have been prepared in accordance with the Financial Reporting Council's (FRC) Financial Reporting Standard 104 Interim Financial Reporting ('FRS 104') and the Statement of Recommended Practice (SORP) for Investment Companies re-issued by the Association of Investment Companies in November 2014. Details of the accounting policies and valuation methodologies are included in the Annual Report.
2. Publication of non-statutory accounts
The unaudited half-yearly results for the six months ended 31 August 2016 do not constitute statutory accounts within the meaning of Section 415 of the Companies Act 2006. The comparative figures for the year ended 29 February 2016 have been extracted from the audited financial statements for that year, which have been delivered to the Registrar of Companies. The independent auditor's report on those financial statements, in accordance with chapter 3, part 16 of the Companies Act 2006, was unqualified. This half-yearly report has not been reviewed by the Company's auditor.
3. Earnings per share
The calculation of earnings per share for the period is based on the return attributable to shareholders divided by the weighted average number of shares in issue during the period. There are no potentially dilutive capital instruments in issue and, therefore, no diluted returns per share figures are relevant.
4. Net asset value per share
The net asset value per share is based on the net assets at the period end divided by the number of shares in issue at that date (5,431,656 in each case).
5. Principal risks and uncertainties
The Company's assets consist of equity and fixed interest investments, cash and liquid resources. Its principal risks are therefore market risk, credit risk and liquidity risk. Other risks faced by the Company include economic, loss of approval as a Venture Capital Trust, investment and strategic, regulatory, reputational, operational and financial risks. These risks, and the way in which they are managed, are described in more detail in the Company's Annual Report and Accounts for the year ended 29 February 2016. The Company's principal risks and uncertainties have not changed materially since the date of that report.
6. Related party transactions
OT1 Managers Ltd, a wholly owned subsidiary, provides investment management services to the Company for a fee of 1% of net assets per annum.
7. Copies of this statement are available from Oxford Technology Management, The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA and on the Company's website - www.oxfordtechnology.com /vct1.
Board Directors : Alex Starling, Robin Goodfellow, Richard Roth and David Livesley
Investment Manager : OT1 Managers Ltd with services contracted to Oxford Technology Management Ltd
Website: www.oxfordtechnology.com/vct1